43
Growth Score
pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
356222
Papillon Therapeutics advances genetic medicines for neurologic, cardiac, and systemic diseases, focusing on HSPC therapies.
- Stephanie Cherqui: Co-FounderPast Role: Stelios Therapeutics, Co-Founder
About the Company
Papillon Therapeutics is a biotechnology company advancing multi-systemic genetic medicines for diseases with neurologic, cardiac, and other systemic manifestations. The company focuses on developing gene-modified hematopoietic stem and progenitor cell (HSPC) therapies, with a lead program targeting Cystinosis. Papillon Therapeutics aims to provide
profound and durable benefits to patients suffering from life-threatening degenerative conditions through innovative genetic treatments.
